389 related articles for article (PubMed ID: 15080795)
1. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Almeida MR; Macedo B; Cardoso I; Alves I; Valencia G; Arsequell G; Planas A; Saraiva MJ
Biochem J; 2004 Jul; 381(Pt 2):351-6. PubMed ID: 15080795
[TBL] [Abstract][Full Text] [Related]
2. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW
J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308
[TBL] [Abstract][Full Text] [Related]
3. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Tojo K; Sekijima Y; Kelly JW; Ikeda S
Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
[TBL] [Abstract][Full Text] [Related]
4. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.
Sekijima Y; Dendle MA; Kelly JW
Amyloid; 2006 Dec; 13(4):236-49. PubMed ID: 17107884
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
[TBL] [Abstract][Full Text] [Related]
6. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Cotrina EY; Pinto M; Bosch L; Vilà M; Blasi D; Quintana J; Centeno NB; Arsequell G; Planas A; Valencia G
J Med Chem; 2013 Nov; 56(22):9110-21. PubMed ID: 24147937
[TBL] [Abstract][Full Text] [Related]
8. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin.
Munro SL; Lim CF; Hall JG; Barlow JW; Craik DJ; Topliss DJ; Stockigt JR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1141-7. PubMed ID: 2498384
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
Cotrina EY; Oliveira Â; Leite JP; Llop J; Gales L; Quintana J; Cardoso I; Arsequell G
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998442
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.
Almeida MR; Alves IL; Terazaki H; Ando Y; Saraiva MJ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1024-8. PubMed ID: 10772944
[TBL] [Abstract][Full Text] [Related]
11. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
Liang Y; Ore MO; Morin S; Wilson DJ
Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
[TBL] [Abstract][Full Text] [Related]
12. Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
Almeida MR; Gales L; Damas AM; Cardoso I; Saraiva MJ
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):587-96. PubMed ID: 16266291
[TBL] [Abstract][Full Text] [Related]
13. CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci.
Mu Y; Jin S; Shen J; Sugano A; Takaoka Y; Qiang L; Imbimbo BP; Yamamura K; Li Z
FEBS Lett; 2015 Mar; 589(7):849-56. PubMed ID: 25728271
[TBL] [Abstract][Full Text] [Related]
14. Iodination of salicylic acid improves its binding to transthyretin.
Gales L; Almeida MR; Arsequell G; Valencia G; Saraiva MJ; Damas AM
Biochim Biophys Acta; 2008 Mar; 1784(3):512-7. PubMed ID: 18155178
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
[TBL] [Abstract][Full Text] [Related]
16. Cooperative stabilization of transthyretin by clusterin and diflunisal.
Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
[TBL] [Abstract][Full Text] [Related]
17. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
[TBL] [Abstract][Full Text] [Related]
18. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.
Miller SR; Sekijima Y; Kelly JW
Lab Invest; 2004 May; 84(5):545-52. PubMed ID: 14968122
[TBL] [Abstract][Full Text] [Related]
19. Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants.
Rosen HN; Moses AC; Murrell JR; Liepnieks JJ; Benson MD
J Clin Endocrinol Metab; 1993 Aug; 77(2):370-4. PubMed ID: 8345041
[TBL] [Abstract][Full Text] [Related]
20. CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.
Qiang L; Guan Y; Li X; Liu L; Mu Y; Sugano A; Takaoka Y; Sakaeda T; Imbimbo BP; Yamamura KI; Jin S; Li Z
Amyloid; 2017 Mar; 24(1):42-51. PubMed ID: 28393633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
